US2016100A
(en)
|
1932-01-06 |
1935-10-01 |
Schwarzkopf Erich |
Thermo-magnetically actuated source of power
|
US2015101A
(en)
|
1933-08-16 |
1935-09-24 |
Edna W Dieckmann |
Terminal fixture aperture indicator
|
US2016103A
(en)
|
1933-09-01 |
1935-10-01 |
Hugo J Chott |
Dental aligning and testing device
|
US2016101A
(en)
|
1934-03-26 |
1935-10-01 |
Charles A Towne |
Apparatus for drawing tabs from addressograph plate carriers
|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
US5837249A
(en)
|
1985-04-19 |
1998-11-17 |
The Wistar Institute |
Method for generating an immunogenic T cell response protective against a virus
|
US5726288A
(en)
|
1989-11-13 |
1998-03-10 |
Massachusetts Institute Of Technology |
Localization and characterization of the Wilms' tumor gene
|
US5229115A
(en)
|
1990-07-26 |
1993-07-20 |
Immunex Corporation |
Adoptive immunotherapy with interleukin-7
|
JPH06505486A
(ja)
|
1991-02-07 |
1994-06-23 |
モレキュメティクス,リミティド |
βターンおよびβバルジのコンフォメーション的に制限された模倣物およびそれらを含有するペプチド
|
WO1994021287A1
(en)
|
1993-03-15 |
1994-09-29 |
The Government Of The United States Of America As Represented By The Department Of Health And Human Services |
Peptide coated dendritic cells as immunogens
|
WO1995029240A1
(en)
|
1994-04-22 |
1995-11-02 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Isolation and characterization of a novel primate t-cell lymphotropic virus and the use of this virus or components thereof in diagnostics assays and vaccines
|
US5622835A
(en)
|
1994-04-28 |
1997-04-22 |
The Wistar Institute Of Anatomy & Biology |
WT1 monoclonal antibodies
|
US5643786A
(en)
|
1995-01-27 |
1997-07-01 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method for isolating dendritic cells
|
US6156316A
(en)
|
1995-05-08 |
2000-12-05 |
Sloan-Kettering Institute For Cancer Research |
Oncogene fusion protein peptide vaccines
|
JPH11171896A
(ja)
|
1995-09-19 |
1999-06-29 |
Kirin Brewery Co Ltd |
新規ペプチド化合物およびその医薬組成物
|
US5981217A
(en)
|
1995-12-11 |
1999-11-09 |
Mayo Foundation For Medical Education And Research |
DNA encoding TGF-β inducible early factor-1 (TIEF-1), a gene expressed by osteoblasts
|
PT879282E
(pt)
|
1996-01-17 |
2003-11-28 |
Imp College Innovations Ltd |
Imunoterapia utilizando linfocitos t citotoxicos (ctl)
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
US6207375B1
(en)
|
1996-12-11 |
2001-03-27 |
Mayo Foundation For Medical Educational & Research |
TGF-β inducible early factor-1 (TIEF-1) and a method to detect breast cancer
|
ID27813A
(id)
|
1998-01-28 |
2001-04-26 |
Corixa Corp |
Senyawa-senyawa untuk terapi dan diagnosa kanker paru-paru dan metoda untuk penggunaannya
|
EP2048160B1
(en)
|
1998-07-31 |
2015-01-07 |
International Institute of Cancer Immunology, Inc. |
Tumor antigen based on products of the tumor suppressor gene WT1
|
US7115272B1
(en)
|
1998-09-30 |
2006-10-03 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7144581B2
(en)
|
2000-10-09 |
2006-12-05 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7329410B1
(en)
|
1998-09-30 |
2008-02-12 |
Corixa Corporation |
Compositions and method for WT1 specific immunotherapy
|
US20120301492A1
(en)
*
|
1998-09-30 |
2012-11-29 |
Corixa Corporation |
Compositions and methods for wt1 specific immunotherapy
|
US20030072767A1
(en)
|
1998-09-30 |
2003-04-17 |
Alexander Gaiger |
Compositions and methods for WT1 specific immunotherapy
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7901693B2
(en)
|
1998-09-30 |
2011-03-08 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US7063854B1
(en)
|
1998-09-30 |
2006-06-20 |
Corixa Corporation |
Composition and methods for WTI specific immunotherapy
|
US7655249B2
(en)
|
1998-09-30 |
2010-02-02 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
GB9823897D0
(en)
|
1998-11-02 |
1998-12-30 |
Imp College Innovations Ltd |
Immunotherapeutic methods and molecules
|
WO2000037491A2
(en)
|
1998-12-22 |
2000-06-29 |
Genset |
Dnas encoding proteins with signal sequences
|
AU3395900A
(en)
|
1999-03-12 |
2000-10-04 |
Human Genome Sciences, Inc. |
Human lung cancer associated gene sequences and polypeptides
|
AU3755800A
(en)
|
1999-03-15 |
2000-10-04 |
Introgen Therapeutics, Inc. |
Dendritic cells transduced with a wild-type self gene elicit potent antitumor immune responses
|
US6593299B1
(en)
|
1999-04-21 |
2003-07-15 |
University Of Florida Research Foundation, Inc. |
Compositions and methods for controlling pests
|
WO2001025273A2
(en)
|
1999-10-04 |
2001-04-12 |
Corixa Corporation |
Compositions and methods for wt1 specific immunotherapy
|
US20030082194A1
(en)
|
2000-02-22 |
2003-05-01 |
Alexander Gaiger |
Compositions and methods for diagnosis and therapy of malignant mesothelioma
|
NZ521430A
(en)
|
2000-02-22 |
2004-04-30 |
Corixa Corp |
Compositions comprising 1-4 antigenic peptide fragments of the Wilms' tumour gene product for treatment or prevention of malignant mesothelioma
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
US6861234B1
(en)
|
2000-04-28 |
2005-03-01 |
Mannkind Corporation |
Method of epitope discovery
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
JP3728439B2
(ja)
|
2001-03-22 |
2005-12-21 |
治夫 杉山 |
Wt1改変ペプチド
|
US8771702B2
(en)
|
2001-03-26 |
2014-07-08 |
The Trustees Of The University Of Pennsylvania |
Non-hemolytic LLO fusion proteins and methods of utilizing same
|
ATE494905T1
(de)
|
2001-06-29 |
2011-01-15 |
Chugai Pharmaceutical Co Ltd |
Krebsimpfstoff mit einem krebs-antigen auf grundlage des produkts aus dem tumorunterdrückungsgen wt1 und einem kationischen liposom
|
US7553494B2
(en)
|
2001-08-24 |
2009-06-30 |
Corixa Corporation |
WT1 fusion proteins
|
EP1447091A4
(en)
|
2001-09-28 |
2008-02-13 |
Institute Of Can International |
NEW METHOD FOR INDUCTION OF ANTIGEN SPECIFIC T CELLS
|
JPWO2003028758A1
(ja)
|
2001-09-28 |
2005-01-13 |
治夫 杉山 |
抗原特異的t細胞の誘導方法
|
US20030072761A1
(en)
|
2001-10-16 |
2003-04-17 |
Lebowitz Jonathan |
Methods and compositions for targeting proteins across the blood brain barrier
|
US20030175272A1
(en)
|
2002-03-07 |
2003-09-18 |
Medcell Biologics, Inc. |
Re-activated T-cells for adoptive immunotherapy
|
AU2003242305A1
(en)
|
2002-06-12 |
2003-12-31 |
Chugai Seiyaku Kabushiki Kaisha |
Hla-a24-restricted cancer antigen peptide
|
WO2004084936A2
(en)
|
2003-02-06 |
2004-10-07 |
Cerus Corporation |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
US20050008618A1
(en)
|
2003-02-27 |
2005-01-13 |
Howard Kaufman |
Composition for delivering an agent to a target cell and uses thereof
|
CA2514288C
(en)
|
2003-03-05 |
2015-07-07 |
Dendreon Corporation |
Compositions and methods employing alternative reading frame polypeptides for the treatment of cancer and infectious disease
|
EP2343083B1
(en)
*
|
2003-06-27 |
2014-01-15 |
International Institute of Cancer Immunology, Inc. |
Method of diagnosing cancer comprising the measurement of WT1-specific CTL precursor cells
|
US20050147621A1
(en)
|
2003-10-10 |
2005-07-07 |
Higgins Darren E. |
Use of bacterial 5' untranslated regions for nucleic acid expression
|
CN100513563C
(zh)
|
2003-11-05 |
2009-07-15 |
株式会社国际癌症免疫研究所 |
Wt1衍生的hla-dr-结合抗原肽
|
EP1708732B2
(en)
|
2003-12-01 |
2016-05-18 |
Sloan-Kettering Institute For Cancer Research |
Synthetic hla binding peptide analogues and uses thereof
|
DE602004020266D1
(de)
|
2003-12-05 |
2009-05-07 |
Multimmune Gmbh |
Therapeutische und diagnostische anti-hsp 70-antikörper
|
EP1550458A1
(en)
|
2003-12-23 |
2005-07-06 |
Vectron Therapeutics AG |
Synergistic liposomal adjuvants
|
WO2005087260A1
(en)
|
2004-03-04 |
2005-09-22 |
Corixa Corporation |
Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof
|
US20050214268A1
(en)
|
2004-03-25 |
2005-09-29 |
Cavanagh William A Iii |
Methods for treating tumors and cancerous tissues
|
US20050221481A1
(en)
|
2004-03-30 |
2005-10-06 |
Istituto Superiore Di Sanita' |
Amplification of T cells from human cord blood in serum-deprived culture stimulated with stem cell factor, interleukin-7 and interleukin-2
|
WO2005095598A1
(ja)
|
2004-03-31 |
2005-10-13 |
International Institute Of Cancer Immunology, Inc. |
Wt1由来の癌抗原ペプチド
|
US9629927B2
(en)
|
2005-07-29 |
2017-04-25 |
Sloan-Kettering Institute For Cancer Research |
Single wall nanotube constructs and uses thereof
|
CA2626238C
(en)
|
2005-10-17 |
2015-10-06 |
Sloan Kettering Institute For Cancer Research |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
CN101336249A
(zh)
|
2005-11-30 |
2008-12-31 |
株式会社癌免疫研究所 |
新型肽化合物
|
PL1988163T3
(pl)
|
2006-02-22 |
2012-11-30 |
Int Inst Cancer Immunology Inc |
Ograniczony do hla-a*3303 peptyd wt1 i zawierająca go kompozycja farmaceutyczna
|
US8288355B2
(en)
|
2006-03-29 |
2012-10-16 |
International Institute Of Cancer Immunology, Inc. |
siRNA specific to WT1 17AA(−)isoform and use thereof
|
WO2007120673A2
(en)
*
|
2006-04-10 |
2007-10-25 |
Sloan Kettering Institute For Cancer Research |
Immunogenic wt-1 peptides and methods of use thereof
|
WO2007120603A2
(en)
|
2006-04-10 |
2007-10-25 |
Sloan Kettering Institute For Cancer Research |
Immunogenic bcr-abl peptides and methods of use thereof
|
NZ600281A
(en)
|
2006-12-27 |
2013-03-28 |
Harvard College |
Compositions and methods for the treatment of infections and tumors
|
CN102335439B
(zh)
|
2006-12-28 |
2015-04-22 |
株式会社癌免疫研究所 |
Hla-a*1101限制的wt1肽及含有其的药物组合物
|
CN105664147A
(zh)
|
2007-02-07 |
2016-06-15 |
日本电气株式会社 |
用于癌症的治疗剂
|
CN104312974B
(zh)
|
2007-02-27 |
2018-09-04 |
株式会社癌免疫研究所 |
活化辅助t细胞的方法以及用于该方法的组合物
|
EA201300101A1
(ru)
|
2007-05-24 |
2014-02-28 |
Глаксосмитклайн Байолоджикалс С.А. |
Лиофилизированная антигенная композиция
|
KR100995340B1
(ko)
|
2007-11-19 |
2010-11-19 |
재단법인서울대학교산학협력재단 |
자연 살해 t 세포의 리간드와 항원을 적재한 단핵구 또는미분화 골수성 세포를 포함하는 백신
|
AU2008332278C1
(en)
|
2007-12-05 |
2013-10-03 |
International Institute Of Cancer Immunology, Inc. |
Cancer vaccine composition
|
KR100900837B1
(ko)
|
2007-12-07 |
2009-06-04 |
(주)두비엘 |
리포펩타이드와 폴리(i:c)를 아쥬반트로 포함하는 강력한백신 조성물
|
EP2283112B1
(en)
|
2008-05-19 |
2016-10-12 |
Aduro Biotech |
Compositions comprising prfa*mutant listeria and methods of use thereof
|
US20110318380A1
(en)
|
2008-10-01 |
2011-12-29 |
Dako Denmark A/S |
MHC Multimers in Cancer Vaccines and Immune Monitoring
|
AR076349A1
(es)
|
2009-04-23 |
2011-06-01 |
Int Inst Cancer Immunology Inc |
Peptido auxiliar del antigeno del cancer
|
US20130288236A1
(en)
|
2009-11-11 |
2013-10-31 |
Quest Diagnostics Investments Incorporated |
Wt1 mutations for prognosis of myeloproliferative disorders
|
US20110136141A1
(en)
|
2009-12-03 |
2011-06-09 |
Abbott Laboratories |
Peptide reagents and method for inhibiting autoantibody antigen binding
|
WO2011100754A1
(en)
|
2010-02-15 |
2011-08-18 |
The Trustees Of The University Of Pennsylvania |
Live listeria-based vaccines for central nervous system therapy
|
SG10202108581TA
(en)
|
2010-10-05 |
2021-09-29 |
Int Inst Cancer Immunology Inc |
Method for activating helper t cell
|
AP2013007158A0
(en)
|
2011-03-11 |
2013-10-31 |
Gilead Calistoga Llc |
Combination therapies for hematologic malignancies
|
CN103764826A
(zh)
|
2011-06-28 |
2014-04-30 |
株式会社癌免疫研究所 |
肽癌抗原-特异性t细胞的受体基因
|
CA2843386A1
(en)
|
2011-07-29 |
2013-02-07 |
Riken |
Cell for use in immunotherapy which contains modified nucleic acid construct encoding wilms tumor gene product or fragment thereof, method for producing said cell, and said nucleic acid construct
|
US9539299B2
(en)
|
2011-10-27 |
2017-01-10 |
International Institute Of Cancer Immunology, Inc. |
Combination therapy with WT1 peptide vaccine and temozolomide
|
WO2013089252A1
(ja)
|
2011-12-14 |
2013-06-20 |
国立大学法人 高知大学 |
ヘルパーt細胞誘導性ポリペプチドの改変
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
CN107557334B
(zh)
|
2012-05-03 |
2021-06-25 |
弗雷德哈钦森癌症研究中心 |
增强亲和力的t细胞受体及其制备方法
|
EP2911683B1
(en)
|
2012-10-23 |
2019-09-25 |
Ubivac, LLC |
Allogeneic autophagosome-enriched composition for the treatment of disease
|
SG10201705028WA
(en)
|
2012-12-17 |
2017-07-28 |
Otsuka Pharma Co Ltd |
Method for activating helper t cell
|
CN104968782B
(zh)
|
2012-12-26 |
2019-09-06 |
生物科莫公司 |
利用人副流感2型病毒载体的疫苗
|
EP3769782A1
(en)
|
2013-01-15 |
2021-01-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
US10071051B2
(en)
|
2013-02-05 |
2018-09-11 |
Nitto Denko Corporation |
WT1 peptide cancer vaccine composition for transdermal administration
|
KR102045029B1
(ko)
|
2013-02-05 |
2019-11-14 |
닛토덴코 가부시키가이샤 |
점막 투여용 wt1 펩티드 암 백신 조성물
|
KR20140100419A
(ko)
|
2013-02-05 |
2014-08-14 |
닛토덴코 가부시키가이샤 |
경피 투여용 wt1 펩티드 암 백신 조성물
|
EP2762156A1
(en)
|
2013-02-05 |
2014-08-06 |
Nitto Denko Corporation |
Tape preparation of WT1 peptide cancer vaccine for transdermal administration
|
WO2014127296A1
(en)
|
2013-02-14 |
2014-08-21 |
Immunocellular Therapeutics, Ltd |
Cancer vaccines and vaccination methods
|
JP6294868B2
(ja)
|
2013-03-12 |
2018-03-14 |
大日本住友製薬株式会社 |
液体水性組成物
|
EA201992251A1
(ru)
|
2013-03-15 |
2020-05-08 |
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания |
Противораковые вакцины и способы лечения с их применением
|
WO2014157692A1
(ja)
|
2013-03-29 |
2014-10-02 |
大日本住友製薬株式会社 |
Wt1抗原ペプチドコンジュゲートワクチン
|
SG11201508521SA
(en)
|
2013-04-25 |
2015-11-27 |
Vaximm Ag |
Salmonella-based vectors for cancer immunotherapy targeting wilms' tumor gene wt1
|
WO2014185387A1
(ja)
|
2013-05-13 |
2014-11-20 |
株式会社癌免疫研究所 |
免疫療法の臨床効果の予測法
|
WO2015002134A1
(ja)
|
2013-07-02 |
2015-01-08 |
公益財団法人がん研究会 |
細胞性免疫誘導ワクチン
|
JP6697386B2
(ja)
|
2013-11-22 |
2020-05-20 |
ザ ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ |
改変された高親和性ヒトt細胞受容体
|
WO2015090584A1
(en)
|
2013-12-18 |
2015-06-25 |
Vaximm Gmbh Mafinex-Technologiezentrum |
Novel msln targeting dna vaccine for cancer immunotherapy
|
EP4070818A3
(en)
|
2014-01-06 |
2023-01-11 |
The Trustees of the University of Pennsylvania |
Pd1 and pdl1 antibodies and vaccine combinations and use of same for immunotherapy
|
JP6005305B2
(ja)
|
2014-02-26 |
2016-10-12 |
テラ株式会社 |
Wt1抗原性ポリペプチド、及び該ポリペプチドを含む抗腫瘍剤
|
US10023841B2
(en)
|
2014-05-23 |
2018-07-17 |
Baylor Research Institute |
Methods and compositions for treating breast cancer with dendritic cell vaccines
|
KR20170092660A
(ko)
|
2014-12-11 |
2017-08-11 |
인터내셔널 인스티튜트 오브 캔서 이무놀로지 인코퍼레이티드 |
혈관 신생병의 면역 요법
|
CN108350411B
(zh)
|
2015-06-25 |
2021-06-22 |
白川利朗 |
口服肿瘤疫苗
|
US20190054112A1
(en)
|
2015-09-18 |
2019-02-21 |
Moderna Therapeutics, Inc. |
Polynucleotide formulations for use in the treatment of renal diseases
|